Mounjaro health benefits found to reverse one year after stopping drug Researchers said their findings “underscore the importance of continued obesity treatment”.…
Weight-loss drugs: is social media promotion to teenagers still a problem? Following an investigation conducted by The Pharmaceutical Journal in 2022, which revealed that weight-loss drugs were being promoted to teenagers on TikTok, we look at whether anything has changed.…
How safe are GLP-1s? As the use of weight-loss drugs continues to increase, there has been a rise in documented side effects. But what are the serious and unwanted effects of these drugs, and is Yellow Card reporting capturing enough information?…
MHRA raids illegal weight-loss jab production line worth more than £250,000 The Medicines and Healthcare products Regulatory Agency has told The Pharmaceutical Journal that the site of the raid is the first illicit production facility for weight-loss medicine discovered in the UK.…
Boots launches support service for patients coming off weight-loss drugs The service will provide users of the Boots Online Doctor weight-loss service unlimited support for 12 months, alongside various resources and ways to seek advice.…
Semaglutide benefits heart health regardless of weight lost Study authors found that the benefits of semaglutide were largely independent of how much weight patients lost in the first four months after taking the drug.…
Health news round-up: community pharmacy services, medicines, obesity and ageing Senior clinical reporter Joanna Robertson summarises some important developments in health news.…
Weight-loss drug complaints to pharmacy regulator hit 150 in a month Glenn Mathieson, lead advisor for professional regulation at the General Pharmaceutical Council, said the regulator received just 12 fitness to practise complaints about weight loss drugs in April 2024.…
Health news round-up: clinical research and interdisciplinary working Senior clinical reporter Joanna Robertson summarises some important developments in health news.…
Beyond GLP-1: the next wave of weight-loss medication innovation From agonists and antagonists to ultrasound therapy, an in-depth look at the drug development pipeline has highlighted several promising new potential weight-loss medicines.…
